gbt
announces
new
employment
inducement
grants
south
san
francisco
globe
newswire
global
blood
therapeutics
gbt
nasdaq
gbt
today
announced
october
compensation
committee
gbt
board
directors
granted
new
employees
options
purchase
aggregate
shares
company
common
stock
per
share
exercise
price
restricted
stock
units
aggregate
shares
company
common
stock
awards
made
gbt
amended
restated
inducement
equity
plan
plan
awards
granted
inducement
material
employees
entering
employment
company
accordance
nasdaq
listing
rule
c
granted
pursuant
terms
plan
plan
adopted
gbt
board
directors
january
amended
restated
time
time
global
blood
therapeutics
global
blood
therapeutics
gbt
biopharmaceutical
company
dedicated
discovery
development
delivery
treatments
provide
hope
underserved
patient
communities
founded
gbt
delivering
goal
transform
treatment
care
sickle
cell
disease
scd
lifelong
devastating
inherited
blood
disorder
company
introduced
voxelotor
first
treatment
directly
inhibits
sickle
hemoglobin
polymerization
root
cause
red
blood
cell
sickling
scd
gbt
also
advancing
pipeline
program
scd
inclacumab
inhibitor
development
address
pain
crises
associated
disease
addition
gbt
drug
discovery
teams
working
new
targets
develop
next
generation
treatments
scd
learn
please
visit
follow
company
twitter
contact
information
steven
immergut
investors
media
simmergut
